Medroxyprogesterone Acetate Injectable Suspension — Class II drug recall D-0400-2025
Ongoing recall by Mckesson Medical-Surgical Inc. Corporate Office, reported 2025-05-07, distributed in FL, MS. Severe thunderstorms caused transit delays of certain cold chain products that were shipped on 02-Apr-2025 and
| Recall number | D-0400-2025 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Ongoing |
| Voluntary or mandated | Voluntary |
| Recalling firm | Mckesson Medical-Surgical Inc. Corporate Office, Richmond, VA, United States |
| Recall initiated | 2025-04-25 |
| Classified | 2025-05-01 |
| Reported by FDA | 2025-05-07 |
| Distributed | FL, MS |
| Quantity | 3 |
| Reason classes | labeling, potency |
| NDC | 55150-0330-01 |
| Lot numbers | 1MP24042 |
| Expiration dates | 2026-06-30 |
Product
Medroxyprogesterone Acetate Injectable Suspension, USP, 150 mg / mL, 1 mL Single-Dose Vial, Rx only, Mfd. in India for: Eugia US LLC, E. Windsor, NJ 08520, NDC 55150-0330-01
Reason for recall
Severe thunderstorms caused transit delays of certain cold chain products that were shipped on 02-Apr-2025 and delivered after the 48-hours specified delivery time, on 07-Apr-2025 and 08-Apr-2025. The affected products may not have been stored at the recommended labeled storage conditions which may have impacted the safety, quality, identity, potency and purity of the product.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0400-2025. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.